First Light Asset Management as of March 31, 2016
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 67 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| NeoGenomics (NEO) | 10.6 | $21M | 3.1M | 6.74 | |
| AtriCure (ATRC) | 7.9 | $16M | 927k | 16.83 | |
| Akorn | 4.3 | $8.4M | 359k | 23.53 | |
| Enzo Biochem (ENZB) | 4.0 | $7.9M | 1.7M | 4.55 | |
| Entellus Medical Cm | 3.6 | $7.2M | 397k | 18.19 | |
| Amedisys (AMED) | 3.6 | $7.1M | 147k | 48.34 | |
| Harvard Bioscience (HBIO) | 3.3 | $6.5M | 2.2M | 3.02 | |
| LHC | 3.1 | $6.1M | 173k | 35.56 | |
| LeMaitre Vascular (LMAT) | 3.1 | $6.1M | 392k | 15.52 | |
| Ligand Pharmaceuticals In (LGND) | 3.1 | $6.1M | 57k | 107.09 | |
| Oxford Immunotec Global | 2.7 | $5.4M | 547k | 9.91 | |
| Teligent | 2.5 | $5.0M | 1.0M | 4.90 | |
| Envision Healthcare Hlds | 2.4 | $4.7M | 231k | 20.40 | |
| Ldr Hldg | 2.3 | $4.6M | 180k | 25.49 | |
| Endologix | 2.2 | $4.4M | 530k | 8.36 | |
| Biotelemetry | 2.1 | $4.3M | 365k | 11.68 | |
| Spectranetics Corporation | 2.1 | $4.1M | 283k | 14.52 | |
| RTI Biologics | 2.0 | $4.0M | 1.0M | 4.00 | |
| Medicines Company | 2.0 | $4.0M | 125k | 31.77 | |
| NxStage Medical | 1.9 | $3.9M | 258k | 14.99 | |
| Immunomedics | 1.9 | $3.9M | 1.5M | 2.50 | |
| Orthofix International Nv Com Stk | 1.8 | $3.5M | 85k | 41.53 | |
| AngioDynamics (ANGO) | 1.7 | $3.4M | 273k | 12.29 | |
| Veracyte (VCYT) | 1.5 | $3.0M | 557k | 5.40 | |
| Physicians Realty Trust | 1.5 | $2.9M | 158k | 18.58 | |
| Bluebird Bio | 1.5 | $2.9M | 68k | 42.51 | |
| HealthStream (HSTM) | 1.3 | $2.6M | 117k | 22.09 | |
| Quidel Corporation | 1.3 | $2.6M | 148k | 17.26 | |
| Streamline Health Solutions | 1.2 | $2.5M | 1.8M | 1.41 | |
| Aratana Therapeutics | 1.2 | $2.5M | 448k | 5.52 | |
| Arrowhead Research | 1.2 | $2.4M | 492k | 4.82 | |
| Tearlab Corp | 1.2 | $2.4M | 3.7M | 0.63 | |
| Bio-techne Corporation (TECH) | 1.2 | $2.3M | 25k | 94.51 | |
| Cynapsus Therapeutics | 1.1 | $2.3M | 192k | 11.90 | |
| Insmed (INSM) | 1.1 | $2.3M | 178k | 12.67 | |
| Alkermes (ALKS) | 1.1 | $2.2M | 63k | 34.19 | |
| Cepheid | 1.1 | $2.1M | 63k | 33.36 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.0 | $1.9M | 24k | 79.50 | |
| BioMarin Pharmaceutical (BMRN) | 0.8 | $1.6M | 19k | 82.47 | |
| Array BioPharma | 0.8 | $1.6M | 526k | 2.95 | |
| Celldex Therapeutics | 0.4 | $797k | 211k | 3.78 | |
| Humana (HUM) | 0.3 | $648k | 3.5k | 183.05 | |
| BioScrip | 0.3 | $647k | 302k | 2.14 | |
| Aetna | 0.3 | $586k | 5.2k | 112.37 | |
| Anthem (ELV) | 0.3 | $569k | 4.1k | 138.95 | |
| Bristol Myers Squibb (BMY) | 0.3 | $530k | 8.3k | 63.93 | |
| Allergan | 0.3 | $545k | 2.0k | 267.81 | |
| Becton, Dickinson and (BDX) | 0.3 | $515k | 3.4k | 151.69 | |
| Mylan Nv | 0.2 | $453k | 9.8k | 46.34 | |
| Steris | 0.2 | $450k | 6.3k | 71.09 | |
| Novartis (NVS) | 0.2 | $440k | 6.1k | 72.49 | |
| Celgene Corporation | 0.2 | $428k | 4.3k | 100.00 | |
| Johnson & Johnson (JNJ) | 0.2 | $413k | 3.8k | 108.12 | |
| United Therapeutics Corporation (UTHR) | 0.2 | $426k | 3.8k | 111.52 | |
| Eli Lilly & Co. (LLY) | 0.2 | $396k | 5.5k | 72.07 | |
| Agile Therapeutics | 0.2 | $382k | 62k | 6.21 | |
| Amgen (AMGN) | 0.2 | $349k | 2.3k | 149.79 | |
| Merck & Co (MRK) | 0.2 | $350k | 6.6k | 52.95 | |
| St. Jude Medical | 0.2 | $333k | 6.1k | 55.00 | |
| Pfizer (PFE) | 0.2 | $312k | 11k | 29.66 | |
| AstraZeneca (AZN) | 0.2 | $320k | 11k | 28.17 | |
| Myriad Genetics (MYGN) | 0.1 | $293k | 7.8k | 37.47 | |
| IRIDEX Corporation (IRIX) | 0.1 | $276k | 27k | 10.22 | |
| Sanofi-Aventis SA (SNY) | 0.1 | $228k | 5.7k | 40.14 | |
| Bio-Rad Laboratories (BIO) | 0.1 | $229k | 1.7k | 136.72 | |
| Endo International | 0.1 | $230k | 8.2k | 28.18 | |
| Agilent Technologies Inc C ommon (A) | 0.1 | $204k | 5.1k | 39.84 |
